We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
526
DELISTED
Ansys
ANSS
| $2.34M | 0.02% |
+26,183
| New | +$2.26M |
|
527
Timken Company
TKR
$9.82B
| $2.32M | 0.02% |
+69,210
| New | +$2.01M |
|
528
Eli Lilly
LLY
$1.07T
| $2.32M | 0.02% |
32,158
-35,449
| -52% | -$2.68M |
|
529
Kimco Realty
KIM
$17.6B
| $2.29M | 0.02% |
+79,675
| New | +$2.15M |
|
|
QTS
530
DELISTED
QTS REALTY TRUST, INC.
QTS
| $2.29M | 0.02% |
48,397
-196,163
| -80% | -$8.76M |
|
|
STAY
531
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $2.29M | 0.02% |
140,452
-455,711
| -76% | -$6.35M |
|
532
Standex International
SXI
$3.68B
| $2.27M | 0.02% |
+29,190
| New | +$2.12M |
|
533
Matthews International
MATW
$864M
| $2.26M | 0.02% |
+43,849
| New | +$2.14M |
|
534
NetEase
NTES
$76.5B
| $2.25M | 0.02% |
+78,185
| New | +$2.34M |
|
535
IPG Photonics
IPGP
$3.89B
| $2.21M | 0.02% |
+23,035
| New | +$1.95M |
|
|
HDP
536
DELISTED
Hortonworks, Inc.
HDP
| $2.2M | 0.02% |
+194,388
| New | +$2.28M |
|
537
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $2.16M | 0.02% |
+57,407
| New | +$2.11M |
|
538
POSCO
PKX
$15.8B
| $2.16M | 0.02% |
+45,619
| New | +$1.8M |
|
|
YELL
539
DELISTED
Yellow Corporation Common Stock
YELL
| $2.14M | 0.02% |
229,742
-283,958
| -55% | -$2.69M |
|
540
Arrow Electronics
ARW
$10.9B
| $2.14M | 0.02% |
33,204
+21,878
| +193% | +$1.21M |
|
|
VSTO
541
DELISTED
Vista Outdoor Inc.
VSTO
| $2.13M | 0.02% |
+41,064
| New | +$1.98M |
|
|
VER
542
DELISTED
VEREIT, Inc.
VER
| $2.09M | 0.02% |
47,109
-49,799
| -51% | -$1.98M |
|
543
Lincoln National
LNC
$7.91B
| $2.06M | 0.02% |
52,670
-102,423
| -66% | -$4M |
|
|
BLT
544
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $2.05M | 0.02% |
+205,661
| New | +$1.97M |
|
545
Oceaneering
OII
$5.25B
| $2.04M | 0.02% |
+61,319
| New | +$1.91M |
|
546
Take-Two Interactive
TTWO
$43B
| $2.03M | 0.02% |
+53,967
| New | +$1.87M |
|
547
Ternium
TX
$9.29B
| $2.03M | 0.02% |
+113,032
| New | +$1.58M |
|
548
O-I Glass
OI
$1.39B
| $2.03M | 0.02% |
127,145
-911,020
| -88% | -$13.1M |
|
549
BlackBerry
BB
$5.01B
| $2.03M | 0.02% |
250,498
-17,437
| -7% | -$131K |
|
550
Bunge Global
BG
$23.6B
| $2.02M | 0.02% |
+35,727
| New | +$2.04M |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.